Session » Biology and Pathology of Bone and Joint - Poster II
-
Abstract Number: 1093
DNA Methylation Defines Joint Specific Differences in Synovial Fibroblasts from OA and RA Patients
-
Abstract Number: 1094
A Dual Role of Bromodomain Containing 1 Protein in Rheumatoid Arthritis Synovial Fibroblasts
-
Abstract Number: 1095
Periarticular Bone Loss in Arthritis Is Induced By Autoantibodies Against Citrullinated Vimentin
-
Abstract Number: 1096
Augmentation of Wnt Signaling By IL-1β in Fibroblast-like Synoviocytes
-
Abstract Number: 1097
Tankyrase Regulates Osteoclastogenesis Via SH3BP2
-
Abstract Number: 1098
ZCCHC6/TUT7 Negatively Regulates Osterix Activity and Influences Osteoblast-Mediated Regulation of Osteoclastogenesis
-
Abstract Number: 1099
Synovial Exosomes Induce Osteoclast Differentiation in Rheumatoid arthritis
-
Abstract Number: 1101
Adalimumab:TNF Complexes Induce a Divergent Proteomic Profile in Human Osteoclast Precursors to That Resembling a Monocytic Cell
-
Abstract Number: 1102
Differentiation of Spongiosa-Derived Mesenchymal Stromal Cells from Osteoporosis and Osteoarthritis Patients Are Influenced By Adipokines
-
Abstract Number: 1103
Gingival Tissue-Derived MSC Cells (GMSC) Suppress Osteoclastogenesis and Bone Erosion in Collagen-Induced Arthritis Thought CD73 Signal Pathway
-
Abstract Number: 1104
Discovery of a Small Molecule Inhibitor of the Wnt Pathway (SM04755) As a Potential Topical Treatment for Chronic Tendinopathy
-
Abstract Number: 1105
Bone Metabolism in Rheumatic Diseases May be Affected By Free Fatty Acids
-
Abstract Number: 1106
Test of the Spleen Tyrosine Kinase Inhibitor Fostamatinib in a Translational Joint Tissue Model Show Significant Effect on Bone, but Not on Synovial Tissue
-
Abstract Number: 1107
Combining Scaffold-Free Cartilage Transplants to Controlled Gene Expression for Therapeutic Application in Rheumatic Disorders
-
Abstract Number: 1108
Protein Citrullinations By PAD Enzymes Promote Dendritic Cell Transdifferentiation into Osteoclast and Generate Targets for RA-Specific Antibodies
-
Abstract Number: 1109
Targeting IL-8 and CXCR1/2 Abrogates RANKL- and ACPA-Mediated Osteoclastogenesis